| 効果 | 増加 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 不明 |
| 被験者数 | 59 |
| 性別 | 不明 |
この研究の注釈：
Men divided into four groups (young and old; lean and obese) and given 2.28g CLA daily alongside 1.28g [Fish Oil] found no significant changes in any measured parameters, except for a decrease in fat mass and increase in lean mass in the young and obese group; a loss of 83g fat mass relative to placebo gaining 742g fat mass (0.82kg difference) over 12 weeks.
Men divided into four groups (young and old; lean and obese) and given 2.28g CLA daily alongside 1.28g [Fish Oil] found no significant changes in any measured parameters, except for a decrease in fat mass and increase in lean mass in the young and obese group; a loss of 83g fat mass relative to placebo gaining 742g fat mass (0.82kg difference) over 12 weeks.
Adiponectin increased in youth (9% lean, 12% obese) and not in the older group.
The Effect Of 6 Months Supplementation With Conjugated Linoleic Acid On Insulin Resistance In Overweight And Obese
| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 83 |
| 性別 | 男女 |
| 年齢 | 30-44, 45-64 |
| 体型 | 肥満, 肥満 |
この研究の注釈：
A 6 month trial with 118 subjects taking 3.4g CLA isomers with 50/50 blend of the c9t11 and t10c12 isomers found no influences on insulin sensitivity as assessed by insulin clamp, HOMA, or quantitivative insulin sensitivity calculations.
Conjugated Linoleic Acid Supplementation For 8 Weeks Does Not Affect Body Composition, Lipid Profile, Or Safety Biomarkers In Overweight, Hyperlipidemic Men
| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 27 |
| 性別 | 男性 |
| 年齢 | 30-44, 45-64 |
| 体型 | 肥満 |
この研究の注釈：
Relative to safflower oil as a control at 3.5g daily, two experimental groups were used. 3.5g of oil comprising 2.7g of 50/50 CLA isomers, and 3.5g oil comprising 2.7g of jsut the c9t11 isomer. Population was overweight and hyperlipidemic men, and no dietary controls were in place (free-living conditions) over 56 days.
Relative to safflower oil as a control at 3.5g daily, two experimental groups were used. 3.5g of oil comprising 2.7g of 50/50 CLA isomers, and 3.5g oil comprising 2.7g of jsut the c9t11 isomer. Population was overweight and hyperlipidemic men, and no dietary controls were in place (free-living conditions) over 56 days.
No differences existed in lean mass, fat mass, or weight; nor were any trends noted. A decrease in circulating TNF-a was noted with both CLA treatments, and all other parameters came back statistically insignificant.
